March 6, 2025
WEST PALM BEACH, FLORIDA — A new post hoc analysis of three phase 3 multiple sclerosis (MS) trials in patients with paramagnetic rim lesions (PRLs) suggests […]
March 6, 2025
In a video published on the Pasteur Institute website on January 2, neuroscientist Gabriel Lepousez, from the Perception and Memory Unit, explores the question: “Why does […]
March 5, 2025
TOPLINE: Increased levels of moderate to vigorous physical activity were associated with a delayed rise in the concentration of phosphorylated tau181 (p-tau181) in blood over time […]
March 4, 2025
The US Food and Drug Administration (FDA) has approved the thrombolytic tenecteplase (TNKase, Genentech) for treatment of acute ischemic stroke in adults. The drug is administered […]
March 4, 2025
Higher consumption of oily fish such as tuna and salmon or lean fish like cod and perch is associated with a reduced risk for disability progression […]
March 3, 2025
WEST PALM BEACH, Fla. — Paramagnetic rim lesions (PRLs) in the central nervous system (CNS) provide a specific diagnosis of multiple sclerosis (MS), but emerging evidence […]
March 3, 2025
WEST PALM BEACH, Fla. — Discontinuing disease-modifying therapies (DMTs) for multiple sclerosis (MS) after prolonged disease stability poses minimal risk for patients aged > 60 years, […]
March 3, 2025
TOPLINE: Cognitive function may decline more quickly in patients with dementia who also have rheumatoid arthritis (RA), a new cohort study suggested. Having dementia and RA […]
March 3, 2025
As biomarker testing for Alzheimer’s disease (AD) evolves, timely and compassionate disclosure of a diagnosis is more complex than ever. Yet, clinicians may struggle with how […]